Skip to search.
 FTSE 100 Up 0.33%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
5.50 Down 0.14(2.48%) 9 Dec 21:00
Prev Close:5.64
Open:5.69
Bid:5.45 x 1000
Ask:5.99 x 400
1y Target Est:6.50
Beta:2.49292
Earnings Date:21 Feb - 27 Feb (Est.)
Day's Range:5.47 - 5.93
52wk Range:1.63 - 10.98
Volume:1,004,451
Avg Vol (3m):774,977
Market Cap:405.67m
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BCRX at this time.

Comparison

Symbol% ChgMkt Cap
BCRXDown 2.48%405.67m
1 0.00%N/A
GSKUp 1.07%90.05b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.90
Quarterly EPS Est (Dec-16) :-0.22
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-0.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback